3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Vomiting
2
Vulvar Neoplasms
1
Vulvar Diseases
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Triple Negative Breast Neoplasms
1
Postoperative Nausea and Vomiting
1
Papillomavirus Infections
1
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Gynecologic Cancer
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Carcinoma, Hepatocellular
1
Carcinoma in Situ
1
Carcinoma
1
Burkitt Lymphoma
1
Breast Neoplasms
1
Interventions
pegaspargase
5
tislelizumab
2
selinexor
2
fludarabine phosphate
2
Whole-Body Irradiation
2
Tacrolimus
2
Radiotherapy
2
Peripheral Blood Stem Cell Transplantation
2
Oxaliplatin
2
Mycophenolic Acid
2
Gemcitabine
2
Etoposide
2
Cyclophosphamide
2
Busulfan
2
Azacitidine
2
Asparaginase
2
sugemalimab
1
relatlimab
1
pembrolizumab
1
gemcitabine-oxaliplatin regimen
1
fludarabine
1
Vorinostat
1
Valganciclovir
1
Transplantation
1
Tomography, X-Ray Computed
1
Thiotepa
1
Therapeutics
1
Sirolimus
1
Positron-Emission Tomography
1
Polymerase Chain Reaction
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Extranodal NK-T-Cell
×
Ondansetron
×
1 year
×
Clear all
No trials found.